Biden Hints At What Could Be Model For Drug Pricing Compromise

By John Wilkerson / October 15, 2020 at 1:31 PM
Joe Biden said he would like to adopt a variation of the German drug pricing model, which makes drug companies justify prices to an independent panel, according to a press pool account of comments the Democratic presidential candidate made Wednesday (Oct 14). The approach could provide a model for a compromise on drug pricing legislation if Biden wins, National Coalition on Health Care President John Rother said. In response to a question about drug prices, Biden said he backs Medicare...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.